QuiVad
My list

Home / Funds / GSA Capital Partners LLP

GSA Capital Partners LLP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSinceFiling
Valneva SEFrance1.21%July 21, 2026AMF
Tobii ABSweden1.20%October 1, 2026
Tessellis SPAItaly1.18%August 24, 2026
Powercell Sweden AB (publ)Sweden1.00%September 11, 2026
Hexagon CompositesNorway0.99%August 24, 2026
RaySearch Laboratories AB (publ)Sweden0.99%October 12, 2026
Hilbert Group AB (publ)Sweden0.88%October 22, 2026
Oncopeptides ABSweden0.88%October 19, 2026
OssDsign ABSweden0.78%October 6, 2026
EuroAPIFrance0.70%October 19, 2026
Hansa Biopharma ABSweden0.70%September 28, 2026
Smart Eye Aktiebolag (publ)Sweden0.70%October 19, 2026
Intrum ABSweden0.69%November 3, 2026
Cantargia ABSweden0.62%October 30, 2026
Trevi - Finanziaria Industriale SPAItaly0.61%August 24, 2026
Nobia ABSweden0.60%October 9, 2026
Tubacex, S.A.Spain0.60%November 2, 2026
Solutions 30 SEFrance0.59%October 12, 2026
Sivers Semiconductors ABSweden0.52%November 2, 2026
DBV TechnologiesFrance0.51%October 15, 2026
Elliptic Laboratories ASANorway0.51%August 26, 2026
Thor Medical ASANorway0.51%October 20, 2026
InventivaFrance0.50%October 20, 2026
MagnoraNorway0.50%November 3, 2026
MedinCellFrance0.50%October 14, 2026
NSI N.V.Netherlands0.50%October 6, 2026

Follow by RSS

Get the moves on GSA Capital Partners LLP by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

4,290 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
March 30, 2022Oncopeptides ABSweden1.04%
March 30, 2022Tessellis SPAItaly0.99%
March 30, 2022Corestate Capital Holding SAGermany0.50%
March 29, 2022Oncopeptides ABSweden1.23%
March 29, 2022Genedrive PLCUnited Kingdom0.70%
March 28, 2022Oncopeptides ABSweden1.40%
March 28, 2022Westwing Group SEGermany0.45%
March 25, 2022Genedrive PLCUnited Kingdom0.62%
March 24, 2022Westwing Group SEGermany0.56%
March 18, 2022Westwing Group SEGermany0.63%
March 18, 2022AO World PLC ORDUnited Kingdom0.60%
March 17, 2022Tessellis SPAItaly1.07%
March 16, 2022Westwing Group SEGermany0.54%
March 11, 2022Kancera ABSweden0.00%
March 3, 2022Kancera ABSweden0.58%
February 28, 2022CellectisFrance0.50%AMF
February 24, 2022Paypoint PLCUnited Kingdom0.50%
February 22, 2022Kancera ABSweden0.69%
February 22, 2022Paypoint PLCUnited Kingdom0.49%
February 21, 2022Oncopeptides ABSweden1.60%
February 17, 2022Genedrive PLCUnited Kingdom0.52%
February 17, 2022Spectrumone AB (publ)Sweden0.00%
February 16, 2022HOME24 SEGermany0.49%
February 16, 2022MC PHY EnergyFrance0.49%February 18, 2022
February 14, 2022Kancera ABSweden0.78%
February 14, 2022Paypoint PLCUnited Kingdom0.50%
February 10, 2022Spectrumone AB (publ)Sweden0.58%
February 10, 2022AO World PLC ORDUnited Kingdom0.50%
February 8, 2022Oncopeptides ABSweden1.56%
February 7, 2022HOME24 SEGermany0.59%
February 4, 2022Spectrumone AB (publ)Sweden0.69%
February 2, 2022Kancera ABSweden0.88%
February 2, 2022HOME24 SEGermany0.69%
February 1, 2022Oncopeptides ABSweden1.40%
February 1, 2022Tessellis SPAItaly1.19%
February 1, 2022Spectrumone AB (publ)Sweden0.78%
January 28, 2022Oncopeptides ABSweden1.30%
January 27, 2022HOME24 SEGermany0.76%
January 26, 2022MC PHY EnergyFrance0.50%February 18, 2022
January 25, 2022Oncopeptides ABSweden1.27%
January 24, 2022Kancera ABSweden0.99%
January 21, 2022Bushveld Minerals LTDUnited Kingdom0.48%
January 20, 2022Oncopeptides ABSweden1.15%
January 19, 2022Oncopeptides ABSweden1.00%
January 19, 2022Spectrumone AB (publ)Sweden0.89%
January 18, 2022Spectrumone AB (publ)Sweden0.93%
January 18, 2022Climeon AB (publ)Sweden0.00%
January 17, 2022Kancera ABSweden1.08%
January 17, 2022Oncopeptides ABSweden0.82%
January 17, 2022Bushveld Minerals LTDUnited Kingdom0.58%

The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.

Download 4,290 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners LLP, data as at November 3, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=23